ABL to present at "Next-Generation Sequencing - on the way to Diagnostics with Roche"

ABL VP R&D, Mr Boulmé, will exhibit the DeepChek® system at the Next Generation Sequencing Workshop (München, 22/23-05.2012) organized by Roche Diagnostics Deutschland. Please see the Workshop program

ABL @ International Drug Resistance Workshop 2012

ABL is pleased to announce the acceptance of four scientific presentations related to DeepChek®-HIV and to the PRIUS study at the International Workshop on HIV & Hepatitis virus drug resistance and curative strategies to be held in Sitges (Spain) (5-9 June 2012). The presenters will be Dr Papathanasopoulos, Dr Garcia, Dr Paredes and Mr Boulmé. More info to come soon.

ABL to present at Roche Sequencing APAC User Conference

ABL CEO, Dr Sayada, will talk about the use of DeepChek® in the context of GS-454 technology. More details soon.

Presentation of DeepChek® at the European Meeting on HIV and Hepatitis

ABL is pleased to announced Dr Garcia presentation "DeepChek® HIV v1.0., a reliable tool for the bioinformatics analysis and resistance interpretation of Massive Ultra Deep Sequencing of HIV genomes" (Poster P 70) at the European Meeting on HIV and Hepatitis Treatment Strategies and Antiviral Drug Resistance (Barcelona, Spain).Click here to receive the poster presentation by email

Peer-Reviewed Publication about the use of TherapyEdge®

ABL is pleased to announce a peer-reviewed article describing the Themba Lethu Hospital HIV/AIDS Cohort where the TherapyEdge system is being used for patient management. Please click here to see the full PDF version of the article.

TALKING HEADS: A service that fills the follow-up gap

As World AIDS Day on Thursday approaches, Kim Hoepfl looks at an NGO that helps keep HIV-positive workers productive.

More information

Biohealthcluster / ABL-DeepChek™

"ABL DeepChek™ Using High-Throughput Sequencing Systems Aids in the Generation of Clinically Meaningful Genotyping Reports for Personalized Healthcare". See the presentationhttp://www.biohealthcluster.lu/News/ABL-DeepChekTM

---

TherapyEdge® Chronic Care Management

Click here to receive the product sheet by email

Agreement with CIDRZ

ABL is pleased to announce the agreement with CIDRZ (Centre for Infectious Diseases Research in Zambia) for the use of ViroScore® Suite at their facilities for the management of the HIV sequences. The TherapyEdge® clinical software is part of the agreement for the clinical documentation of HIV drug resistance data. More details to come soon. More about CIDRZ